《公司業績》維他奶國際(00345.HK)全年盈轉虧蝕1.59億元 不派息
維他奶國際(00345.HK)公佈截至今年3月底止全年業績,盈轉虧蝕1.59億元,上年同期賺5.48億元;每股虧損14.9仙。公司表示將優先專注業務復甦,不派發未期息。
年內收入達65.01億元,按年跌13.5%。經營虧損爲2.13億元,對比上年錄得溢利8.43億元,主要受中國內地銷售疲弱及政府補貼減少所影響。毛利率由 53%下跌至47%;而EBITDA佔銷售利潤率則由17%下跌至5%。
以當地貨幣計算,年內維他奶中國的收入下跌28%,由於人民幣升值,收入按港元計值則下跌23%。至於香港業務方面,年度銷售淨額達19.34億元,較去年上升4%。展望未來,公司表示將透過加強執行、擴展及創新能力,投資建立品牌價值及提升所有市場的供應,致力恢復按年盈利增長,目前已在部分市場調高價格,並將繼續選擇性提價,採取嚴格的內部成本控制措施以保障利潤率。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.